About the Company
We do not have any company description for Pacira BioSciences, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PCRX News
Pacira's (PCRX) Knee Osteoarthritis Drug Gets FDA's RMAT Tag
Pacira BioSciences, Inc. PCRX announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to PCRX-201 (enekinragene inzadenovec), the company’s novel ...
Commit To Purchase Pacira BioSciences At $15, Earn 12.5% Annualized Using Options
Investors considering a purchase of Pacira BioSciences Inc (Symbol: PCRX) shares, but cautious about paying the going market price of $29.22/share, might benefit from considering selling puts ...
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
Feb. 29, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported ...
Pacira BioSciences Inc PCRX
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Oversold Conditions For Pacira BioSciences (PCRX)
In trading on Monday, shares of Pacira BioSciences Inc (Symbol: PCRX) entered into oversold territory, hitting an RSI reading of 29.3, after changing hands as low as $25.84 per share. By ...
Navigating 4 Analyst Ratings For Pacira BioSciences
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients.
Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference
TAMPA, Fla., March 06, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the Barclays 26 th Annual Global ...
Pacira BioSciences Inc. Registered Shares DL-,001 Aktie
Bitte entschuldigen Sie den Fehler. Sollte dieser Fehler erneut auftreten, kontaktieren Sie bitte unseren Kundeservice per E-Mail.
Pacira BioSciences Inc PCRX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Pacira BioSciences Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Pacira BioSciences Inc.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Loading the latest forecasts...